Solu-Medrone powder and solvent for solution for injection or concentrate for solution for infusion 1000 mg/vial.

DRUG2 trials

Sponsors

Princess Maxima Center For Pediatric Oncology, Prinses Maxima Centrum voor Kinderoncologie B.V.

Conditions

Acute Myeloid LeukemiaAcute lymphoblastic leukemia

Phase 3

Interfant-21: International collaborative treatment protocol for infants under one year with KMT2A-rearranged acute lymphoblastic leukemia or mixed phenotype acute leukemia

SuspendedCTIS2022-502503-30-00

Princess Maxima Center For Pediatric OncologyAcute lymphoblastic leukemia

Start: 2022-12-15Target: 206Updated: 2026-01-27

CHIP-AML22 Master protocol: An open label complex clinical trial in newly diagnosed pediatric de novo AML patients – a study by the NOPHO-DB-SHIP consortium Master Protocol

RecruitingCTIS2023-504999-25-00

Prinses Maxima Centrum voor Kinderoncologie B.V.Acute Myeloid Leukemia

Start: 2023-07-14Target: 675Updated: 2025-08-14